The Europe Protein Therapeutics Market would witness market growth of 6.5% CAGR during the forecast period (2022-2028).
Comparing protein treatments to small-molecule medicines, there are various benefits. First, proteins frequently perform a variety of intricate and highly complex tasks that cannot be duplicated by straightforward chemical substances. These estimations present a significant challenge to modern medicine from the perspective of disease processes since each one of these proteins can cause disease if it has mutations or other abnormalities, or if its concentration is unusually high or low.
But when observed from the standpoint of therapeutics, these estimations provide an excellent opportunity to use protein therapies to treat disease. The US Food and Drug Administration (FDA) has currently approved the use of more than 130 distinct proteins or peptides, and many more are in the development stage. Furthermore, because proteins behave in extremely precise ways, there is frequently less chance that using protein therapies may disrupt regular biological functions and have unfavorable effects.
Moreover, because many of the therapeutic proteins are produced by the body naturally, these drugs are frequently well tolerated and less likely to trigger immunological reactions. Protein treatments can offer effective replacement therapy without the requirement for gene therapy that is not currently available for the majority of genetic illnesses, for diseases in which, a gene is mutated or deleted.
The European economy is supported by the industry for plasma-derived medicines. These economic repercussions take the form of induced, indirect, and direct effects. To put it another way, in addition to the direct impact on the industry that produces plasma-derived medicines, the economic impacts ripple through the entire supply chain, including contractors as well as the value that is created for employees. The number of licensed biosimilars is anticipated to rise in the following years due to the imminent patent cliff for a number of blockbuster therapeutic protein medicines.
The Germany market dominated the Europe Protein Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $32,064.9 million by 2028. The UK market is exhibiting a CAGR of 5.6% during (2022 - 2028). Additionally, The France market is poised to grow at a CAGR of 7.2% during (2022 - 2028).
Based on Product, the market is segmented into Monoclonal Antibodies, Human Growth Hormone, Fusion Protein, Insulin, Erythropoietin, Interferon and Follicle Stimulating Hormone. Based on Application, the market is segmented into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Protein Therapeutics Market will Hit $490.2 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Monoclonal Antibodies
- Human Growth Hormone
- Fusion Protein
- Insulin
- Erythropoietin
- Interferon
- Follicle Stimulating Hormone
By Application
- Metabolic Disorders
- Immunologic Disorders
- Hematological Disorders
- Cancer
- Hormonal Disorders
- Genetic Disorders
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Baxter International, Inc.
- Amgen, Inc.
- F. Hoffmann-La Roche Ltd.
- Eli Lilly And Company
- Merck & Co., Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Pfizer, Inc.
- Novo Nordisk A/S
- Sanofi S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Protein Therapeutics Market, by Product
1.4.2 Europe Protein Therapeutics Market, by Application
1.4.3 Europe Protein Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Product Launches and Product Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
Chapter 4. Europe Protein Therapeutics Market by Product
4.1 Europe Monoclonal Antibodies Market by Country
4.2 Europe Human Growth Hormone Market by Country
4.3 Europe Fusion Protein Market by Country
4.4 Europe Insulin Market by Country
4.5 Europe Erythropoietin Market by Country
4.6 Europe Interferon Market by Country
4.7 Europe Follicle Stimulating Hormone Market by Country
Chapter 5. Europe Protein Therapeutics Market by Application
5.1 Europe Metabolic Disorders Market by Country
5.2 Europe Immunologic Disorders Market by Country
5.3 Europe Hematological Disorders Market by Country
5.4 Europe Cancer Market by Country
5.5 Europe Hormonal Disorders Market by Country
5.6 Europe Genetic Disorders Market by Country
5.7 Europe Others Market by Country
Chapter 6. Europe Protein Therapeutics Market by Country
6.1 Germany Protein Therapeutics Market
6.1.1 Germany Protein Therapeutics Market by Product
6.1.2 Germany Protein Therapeutics Market by Application
6.2 UK Protein Therapeutics Market
6.2.1 UK Protein Therapeutics Market by Product
6.2.2 UK Protein Therapeutics Market by Application
6.3 France Protein Therapeutics Market
6.3.1 France Protein Therapeutics Market by Product
6.3.2 France Protein Therapeutics Market by Application
6.4 Russia Protein Therapeutics Market
6.4.1 Russia Protein Therapeutics Market by Product
6.4.2 Russia Protein Therapeutics Market by Application
6.5 Spain Protein Therapeutics Market
6.5.1 Spain Protein Therapeutics Market by Product
6.5.2 Spain Protein Therapeutics Market by Application
6.6 Italy Protein Therapeutics Market
6.6.1 Italy Protein Therapeutics Market by Product
6.6.2 Italy Protein Therapeutics Market by Application
6.7 Rest of Europe Protein Therapeutics Market
6.7.1 Rest of Europe Protein Therapeutics Market by Product
6.7.2 Rest of Europe Protein Therapeutics Market by Application
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.5.2 Acquisition and Mergers:
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Eli Lilly And Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 Johnson & Johnson (Janssen Global Services, LLC)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental &Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Novo Nordisk A/S
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
TABLE 1 Europe Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Europe Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Protein Therapeutics Market
TABLE 6 Trial and Approvals– Protein Therapeutics Market
TABLE 7 Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 8 Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 9 Europe Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Insulin Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Insulin Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Interferon Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Interferon Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 Europe Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 41 Germany Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 42 Germany Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 43 Germany Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 44 Germany Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 45 Germany Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 46 Germany Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 47 UK Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 48 UK Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 49 UK Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 50 UK Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 51 UK Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 52 UK Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 53 France Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 54 France Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 55 France Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 56 France Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 57 France Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 58 France Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 59 Russia Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 Russia Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 Russia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 62 Russia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 63 Russia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 Russia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 Spain Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 66 Spain Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 67 Spain Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 68 Spain Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 69 Spain Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 70 Spain Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 71 Italy Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 72 Italy Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 73 Italy Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 74 Italy Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 75 Italy Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 76 Italy Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 77 Rest of Europe Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 78 Rest of Europe Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Baxter International, Inc.
TABLE 85 Key Information – Amgen, Inc.
TABLE 86 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 87 Key Information – Eli Lilly And Company
TABLE 88 KEY INFORMATION - MERCK & CO., INC.
TABLE 89 Key information –Johnson & Johnson
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key information – Novo Nordisk A/S
TABLE 92 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Merck & Co., Inc.